- Report
- August 2025
- 189 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- February 2026
- 388 Pages
Global
From €6126EUR$6,995USD£5,317GBP
- Report
- February 2026
- 681 Pages
Global
From €6126EUR$6,995USD£5,317GBP
- Report
- December 2025
- 150 Pages
Global
From €5211EUR$5,950USD£4,523GBP
- Report
- April 2025
- 120 Pages
Global
From €5211EUR$5,950USD£4,523GBP
- Report
- April 2025
- 120 Pages
Global
From €5211EUR$5,950USD£4,523GBP
- Report
- October 2025
- 150 Pages
Global
From €3502EUR$3,999USD£3,040GBP
- Report
- February 2025
- 148 Pages
Global
From €3502EUR$3,999USD£3,040GBP
- Report
- February 2025
- 100 Pages
Global
From €5211EUR$5,950USD£4,523GBP
- Report
- April 2025
- 200 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- January 2026
- 191 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 194 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 185 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 191 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 189 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 182 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 184 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 185 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 187 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 191 Pages
Global
From €3450EUR$3,939USD£2,994GBP

High Throughput Sequencing (HTS) is a biotechnology technique used to rapidly sequence large amounts of DNA or RNA. It is used to identify genetic variations, detect mutations, and analyze gene expression. HTS is used in a variety of applications, including drug discovery, diagnostics, and personalized medicine. It is also used in research to study the genetic basis of diseases, to identify biomarkers, and to understand the evolution of species.
HTS has revolutionized the biotechnology industry, allowing researchers to quickly and accurately sequence large amounts of genetic material. This has enabled the development of new treatments and diagnostics, as well as the identification of new biomarkers.
Companies in the HTS market include Illumina, Thermo Fisher Scientific, BGI, Pacific Biosciences, Oxford Nanopore Technologies, and 10X Genomics. Show Less Read more